164 related articles for article (PubMed ID: 33724487)
1. IgE-cross-blocking antibodies to Fagales following sublingual immunotherapy with recombinant Bet v 1.
Grilo JR; Kitzmüller C; Aglas L; Sánchez Acosta G; Vollmann U; Ebner C; Horak F; Kinaciyan T; Radauer C; Ferreira F; Jahn-Schmid B; Bohle B
Allergy; 2021 Aug; 76(8):2555-2564. PubMed ID: 33724487
[TBL] [Abstract][Full Text] [Related]
2. IgE-blocking antibodies following SLIT with recombinant Mal d 1 accord with improved apple allergy.
Sánchez Acosta G; Kinaciyan T; Kitzmüller C; Möbs C; Pfützner W; Bohle B
J Allergy Clin Immunol; 2020 Oct; 146(4):894-900.e2. PubMed ID: 32259540
[TBL] [Abstract][Full Text] [Related]
3. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen.
Subbarayal B; Schiller D; Möbs C; de Jong NW; Ebner C; Reider N; Bartel D; Lidholm J; Pfützner W; Gerth van Wijk R; Vieths S; Bohle B
Allergy; 2013 Nov; 68(11):1377-86. PubMed ID: 24053565
[TBL] [Abstract][Full Text] [Related]
4. Bet v 1-like pollen allergens of multiple Fagales species can sensitize atopic individuals.
Hauser M; Asam C; Himly M; Palazzo P; Voltolini S; Montanari C; Briza P; Bernardi ML; Mari A; Ferreira F; Wallner M
Clin Exp Allergy; 2011 Dec; 41(12):1804-14. PubMed ID: 22092996
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of 4 months of sublingual immunotherapy with recombinant Mal d 1 and Bet v 1 in patients with birch pollen-related apple allergy.
Kinaciyan T; Nagl B; Faustmann S; Frommlet F; Kopp S; Wolkersdorfer M; Wöhrl S; Bastl K; Huber H; Berger U; Bohle B
J Allergy Clin Immunol; 2018 Mar; 141(3):1002-1008. PubMed ID: 28870463
[TBL] [Abstract][Full Text] [Related]
6. The role of IgG
Strobl MR; Demir H; Sánchez Acosta G; Drescher A; Kitzmüller C; Möbs C; Pfützner W; Bohle B
J Allergy Clin Immunol; 2023 May; 151(5):1371-1378.e5. PubMed ID: 36657603
[TBL] [Abstract][Full Text] [Related]
7. Bet v 1-independent sensitization to major allergens in Fagales pollen: Evidence at the T-cell level.
Polak D; Vollmann U; Grilo J; Bogdanov IV; Aglas L; Ovchinnikova TV; Ferreira F; Bohle B
Allergy; 2023 Mar; 78(3):743-751. PubMed ID: 36424884
[TBL] [Abstract][Full Text] [Related]
8. Recombinant birch pollen allergens (rBet v 1 and rBet v 2) contain most of the IgE epitopes present in birch, alder, hornbeam, hazel, and oak pollen: a quantitative IgE inhibition study with sera from different populations.
Niederberger V; Pauli G; Grönlund H; Fröschl R; Rumpold H; Kraft D; Valenta R; Spitzauer S
J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):579-91. PubMed ID: 9802365
[TBL] [Abstract][Full Text] [Related]
9.
Aglas L; Bethanis A; Chrusciel P; Stolz F; Gruen M; Jaakkola UM; Jongejan L; Yatkin E; Van Ree R
Front Immunol; 2020; 11():2118. PubMed ID: 33013894
[TBL] [Abstract][Full Text] [Related]
10. T cells specific to multiple Bet v 1 peptides are highly cross-reactive toward the corresponding peptides from the homologous group of tree pollens.
Lund G; Christensen LH; Ihlemann J; Andersen PS; Wambre E; Würtzen PA; Gupta S
Front Immunol; 2023; 14():1291666. PubMed ID: 38077382
[TBL] [Abstract][Full Text] [Related]
11. Natural human Bet v 1-specific IgG antibodies recognize non-conformational epitopes whereas IgE reacts with conformational epitopes.
Brazhnikov G; Smolnikov E; Litovkina A; Jiang T; Shatilov A; Tulaeva I; Tulaev M; Karaulov A; Poroshina A; Zhernov Y; Focke-Tejkl M; Weber M; Akinfenwa O; Elisyutina O; Andreev S; Shilovskiy I; Shershakova N; Smirnov V; Fedenko E; Lepeshkova TS; Beltyukov EC; Naumova VV; Kundi M; Khaitov M; Wiedermann U; Valenta R; Campana R
Allergy; 2023 Dec; 78(12):3136-3153. PubMed ID: 37701941
[TBL] [Abstract][Full Text] [Related]
12. Fagales pollen sensitization in a birch-free area: a respiratory cohort survey using Fagales pollen extracts and birch recombinant allergens (rBet v 1, rBet v 2, rBet v 4).
Mari A; Wallner M; Ferreira F
Clin Exp Allergy; 2003 Oct; 33(10):1419-28. PubMed ID: 14519150
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the antibody responses induced by subcutaneous injection immunotherapy with birch and Fagales pollen extracts adsorbed onto aluminum hydroxide.
Gadermaier E; Flicker S; Aberer W; Egger C; Reider N; Focke M; Vrtala S; Kundi M; Valenta R
Int Arch Allergy Immunol; 2010; 151(1):17-27. PubMed ID: 19672093
[TBL] [Abstract][Full Text] [Related]
14. IgE, IgG4 and IgA specific to Bet v 1-related food allergens do not predict oral allergy syndrome.
Guhsl EE; Hofstetter G; Lengger N; Hemmer W; Ebner C; Fröschl R; Bublin M; Lupinek C; Breiteneder H; Radauer C
Allergy; 2015 Jan; 70(1):59-66. PubMed ID: 25327982
[TBL] [Abstract][Full Text] [Related]
15. Vaccines for birch pollen allergy based on genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1.
Mahler V; Vrtala S; Kuss O; Diepgen TL; Suck R; Cromwell O; Fiebig H; Hartl A; Thalhamer J; Schuler G; Kraft D; Valenta R
Clin Exp Allergy; 2004 Jan; 34(1):115-22. PubMed ID: 14720271
[TBL] [Abstract][Full Text] [Related]
16. How far can we simplify in vitro diagnostics for Fagales tree pollen allergy? A study with three whole pollen extracts and purified natural and recombinant allergens.
Van Ree R; Van Leeuwen WA; Akkerdaas JH; Aalberse RC
Clin Exp Allergy; 1999 Jun; 29(6):848-55. PubMed ID: 10336603
[TBL] [Abstract][Full Text] [Related]
17. Isotype-specific binding patterns of serum antibodies to multiple conformational epitopes of Bet v 1.
Schmalz S; Mayr V; Shosherova A; Gepp B; Ackerbauer D; Sturm G; Bohle B; Breiteneder H; Radauer C
J Allergy Clin Immunol; 2022 May; 149(5):1786-1794.e12. PubMed ID: 34740603
[TBL] [Abstract][Full Text] [Related]
18. Filling the Antibody Pipeline in Allergy: PIPE Cloning of IgE, IgG
Köhler VK; Crescioli S; Fazekas-Singer J; Bax HJ; Hofer G; Pranger CL; Hufnagl K; Bianchini R; Flicker S; Keller W; Karagiannis SN; Jensen-Jarolim E
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32784509
[TBL] [Abstract][Full Text] [Related]
19. T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies.
Vrtala S; Akdis CA; Budak F; Akdis M; Blaser K; Kraft D; Valenta R
J Immunol; 2000 Dec; 165(11):6653-9. PubMed ID: 11086111
[TBL] [Abstract][Full Text] [Related]
20. A nonallergenic birch pollen allergy vaccine consisting of hepatitis PreS-fused Bet v 1 peptides focuses blocking IgG toward IgE epitopes and shifts immune responses to a tolerogenic and Th1 phenotype.
Marth K; Breyer I; Focke-Tejkl M; Blatt K; Shamji MH; Layhadi J; Gieras A; Swoboda I; Zafred D; Keller W; Valent P; Durham SR; Valenta R
J Immunol; 2013 Apr; 190(7):3068-78. PubMed ID: 23440415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
